Towards Precision Medicine for Diabetes in Pregnancy
Recruiting
- Conditions
- Diabetes in PregnancyGestational Diabetes1001842410026908
- Registration Number
- NL-OMON51350
- Lead Sponsor
- Zuyderland Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
having a confirmed single, viable pregnancy past 20 weeks gestation
Diagnosed GDM and treated with Metformin (as prescribed by Ob/Gyn)
Exclusion Criteria
pre-existing diabetes
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Study parameters will be collected at mid-gestation (24-27 weeks), end<br /><br>gestation (35-37 weeks), and 6 weeks after delivery, as indicated in Table 1.<br /><br><br /><br>Primary outcomes of this study will be time in range during 7 days continuous<br /><br>glucose monitoring. Requirement for additional insulin-treatment will be<br /><br>abstracted from medical records and reported in %.</p><br>
- Secondary Outcome Measures
Name Time Method